Here are the 10-K annual reports from Innovative Medtech Inc (IMTH) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow IMTH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IMTH filings page.
AnTix Holdings, Inc. (IMTH) reports results for the year ended June 30, 2025, highlighting a major business shift and balance sheet changes. The company posted net income of $1,268,903, compared with a net loss of $7,938,897 the prior year, driven largely by a $3,366,943 gain on the disposition of its SarahCare adult day services subsidiaries and income from discontinued operations.
The core business generated no revenue from continuing operations in 2025, while operating expenses from continuing operations fell to $2,728,979 from $4,003,417, mainly due to lower stock-based compensation and consulting costs. Other income was helped by a $1,140,708 gain on extinguishment of debt, partially offset by a $440,800 impairment on deposits for acquisitions.
The company is exiting adult day services and repositioning as a technology-focused ticketing and media business built around Ticketbash’s artificial intelligence and dynamic pricing software, while maintaining a health and wellness presence through an exclusive Oral Thrush license. Despite reporting net income, AnTix has cumulative losses of $43,292,307, cash of $13,616, a working capital deficit of $1,280,533, and its auditors and management disclose substantial doubt about its ability to continue as a going concern.